Circulating serum amyloid A levels but not SAA1 variants predict long-term outcomes of angiographically confirmed coronary artery disease

CCUR > College of Natural Science and Engineering > College of Science > Department of Biology > journal articles > Item 987654321/50416

Please use this identifier to cite or link to this item: https://irlib.pccu.edu.tw/handle/987654321/50416

Title:	Circulating serum amyloid A levels but not SAA1 variants predict long-term outcomes of angiographically confirmed coronary artery disease
Authors:	Yeh, Kuan-Hung Hsu, Lung-An Juang, Jyh-Ming Jimmy Chiang, Fu-Tien Teng, Ming-Sheng Tzeng, I-Shiang Wu, Semon Lin, Jeng-Feng Ko, Yu-Lin
Contributors:	Department of Life Science
Keywords:	Coronary artery disease;Genome-wide association study;Long-term outcomes;SAA1 gene;Serum amyloid A
Date:	2022-10
Issue Date:	2022-11-22 15:20:25 (UTC+8)
Publisher:	Wolters Kluwer Medknow Publications
Abstract:	Objectives: Circulating serum amyloid A (SAA) levels are strongly associated with atherosclerotic cardiovascular disease risk and severity. The association between SAA1 genetic variants, SAA levels, inflammatory marker levels, and coronary artery disease (CAD) prognosis has not been fully understood. Materials and Methods: In total, 2199 Taiwan Biobank (TWB) participants were enrolled for a genome-wide association study (GWAS), and the long-term outcomes in 481 patients with CAD were analyzed. The primary endpoint was all-cause mortality, and the secondary endpoint was the combination of all-cause death, myocardial infarction, stroke, and hospitalization for heart failure. Results: Through GWAS, SAA1 rs11024600 and rs7112278 were independently associated with SAA levels (P = 3.84 × 10−145 and P = 1.05 × 10−29, respectively). SAA levels were positively associated with leukocyte counts and multiple inflammatory marker levels in CAD patients and with body mass index, hemoglobin, high-density lipoprotein cholesterol, and alanine aminotransferase levels in TWB participants. By stepwise linear regression analysis, SAA1 gene variants contributed to 27.53% and 8.07% of the variation of the SAA levels in TWB and CAD populations, respectively, revealing a stronger influence of these two variants in TWB participants compared to CAD patients. Kaplan–Meier survival analysis revealed that SAA levels, but not SAA1 gene variants, were associated with long-term outcomes in patients with CAD. Cox regression analysis also indicated that high circulating SAA levels were an independent predictor of both the primary and secondary endpoints. Conclusion: SAA1 genotypes contributed significantly to SAA levels in the general population and in patients with CAD. Circulating SAA levels but not SAA1 genetic variants could predict long-term outcomes in patients with angiographically confirmed CAD.
Relation:	Tzu Chi Medical Journal 開放取用卷 34, 期 4, 頁 423 - 4331 October 2022
Appears in Collections:	[Department of Biology ] journal articles

Files in This Item:

File	Description	Size	Format
index.html		0Kb	HTML	219	View/Open

View Licence

Loading...